Mechanism of Action of Anakinra
Introduction Anakinra is a recombinant human interleukin‑1 receptor antagonist (IL‑1Ra) used to treat rheumatoid arthritis, neonatal-onset multisystem inflammatory … Read more
Mechanism of Action
Mechanism of Action of Stelara (Ustekinumab)
Introduction Stelara (ustekinumab) is a fully human IgG1κ monoclonal antibody designed to target key cytokines involved in immune-mediated … Read more
Mechanism of Action of Farxiga (Dapagliflozin)
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more
Mechanism of Action of Semaglutide (Ozempic/Wegovy)
Introduction Semaglutide (Ozempic for diabetes; Wegovy for obesity) is a GLP‑1 receptor agonist used for type 2 diabetes mellitus … Read more
Mechanism of Action of Bupropion
Introduction Bupropion is an atypical antidepressant primarily used to treat major depressive disorder, seasonal affective disorder, and as … Read more
Mechanism of Action of Lokelma (Sodium Zirconium Cyclosilicate)
Introduction Lokelma is an oral, non-absorbed potassium binder used to treat hyperkalemia. It works by selectively trapping potassium … Read more
Mechanism of Action of Finerenone (Kerendia)
Introduction Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) approved for reducing the risk of cardiovascular and … Read more
Mechanism of Action of Mounjaro (Tirzepatide)
Introduction Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, is a dual GIP/GLP‑1 receptor … Read more
Mechanism of Action of Entresto (Sacubitril/Valsartan)
Introduction Entresto is a combination drug containing sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker … Read more
Mechanism of Action of Octreotide
Introduction Octreotide is a synthetic somatostatin analog used to treat acromegaly, carcinoid syndrome, VIPoma, and control of panhormonal … Read more